- cafead   Jun 24, 2024 at 10:22: PM
via The U.S. Court of Appeals for the District of Columbia must reevaluate whether the plaintiffs can go forward with their claims in the case involving 21 pharmaceutical and medical device companies, including AstraZeneca, GE Healthcare Technologies, Johnson & Johnson, Pfizer and Roche.
article source
article source